Literature DB >> 6368699

Regional variation in the expression of bullous pemphigoid antigen and location of lesions in bullous pemphigoid.

D J Goldberg, M Sabolinski, J C Bystryn.   

Abstract

The expression of bullous pemphigoid (BP) antigen in different locations on the body was estimated from the highest dilution of BP sera giving a positive reaction at a site by indirect immunofluorescence. Three sera with high titers (640-1280) of BP antibodies against monkey and guinea pig esophagus were reacted with 46 specimens of normal human skin. There was marked variation in the expression of BP antigen in skin obtained from different sites. The greatest expression of BP antigen was in skin obtained from the flexor surfaces of the arm, leg, and thigh. All specimens from these sites reacted with high dilutions (1:640-1:2560) of BP antibodies. BP antigen was expressed least in skin specimens from scalp, face, and extensor surface of the arm. No BP antigen could be demonstrated in 17% of specimens from these locations and the remainder reacted only with low dilutions (1:40-1:160) of BP antibodies. Skin from trunk, knee, and extensor thigh had intermediate amounts of BP antigen. Similar results were seen with all 3 BP sera. Similar reactions were observed in multiple skin specimens obtained from different sites in the same individual. Of note is that the greatest expression of BP antigen was in areas commonly involved in this disease (flexural surfaces), whereas the least was seen in areas (scalp, face, extensor arm) which are rarely involved. The apparent correlation between the expression of BP antigen and the location of lesions in bullous pemphigoid, suggests that BP antigen expression may play a role in the distribution of skin lesions in this disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368699     DOI: 10.1111/1523-1747.ep12260627

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

Review 1.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Antigen specificities of antibasement membrane zone antibodies: immunofluorescence and Western immunoblotting studies.

Authors:  T Muramatsu; T Shirai; T Iida; Y Yamashina; K Sakamoto
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

3.  Bullous pemphigoid antigen concentration in normal human skin in relation to body area and age.

Authors:  G Hamm; K D Wozniak
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

4.  Soluble peptide treatment reverses CD8 T-cell-induced disease in a mouse model of spontaneous tissue-selective autoimmunity.

Authors:  So Yeon Paek; Fumi Miyagawa; Hong Zhang; Jay T Linton; Shelley B Hoover; R Mark Simpson; Stephen I Katz
Journal:  J Invest Dermatol       Date:  2011-11-17       Impact factor: 8.551

5.  Seborrheic pemphigoid.

Authors:  Lucia Lourdes O Castro-Forés; Jamaine Melisse L Cruz; Maria Jasmin J Jamora; Katrina M Canlas-Estrella
Journal:  JAAD Case Rep       Date:  2016-02-27

6.  Regional variations in antigenic properties of skin. A possible cause for disease-specific distribution of skin lesions.

Authors:  L Sison-Fonacier; J C Bystryn
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

7.  Seborrheic pemphigoid.

Authors:  Enzo Errichetti; Giuseppe Stinco; Enrico Pegolo; Nicola di Meo; Giusto Trevisan; Pasquale Patrone
Journal:  Case Rep Dermatol Med       Date:  2014-08-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.